Warning letter
Greer Laboratories, Inc.: warning letter of Jun 24, 2005
FDA warning letter UCM075460 · Office of Enforcement
Key facts
| Reference number | UCM075460 |
|---|---|
| Company | Greer Laboratories, Inc. |
| Subject | CGMP for Finished Pharmaceutical |
| Issue date | Jun 24, 2005 |
| Posted date | Jun 24, 2005 |
| Issuing office | Office of Enforcement |
| Product type | Drugs |
| CFR sections cited | 600.14, 211, 211.42(c)(10), 211.42(c)(10)(iv), 211.42(c)(10)(v), 211.113(b), 211.137(a), 211.180(e), 601.12, 601.12(b) |
| Country | 3 |
| Inspection city | Lenoir |
| Inspection ZIP | 28645-3646 |
| Inspection start date | Feb 14, 2005 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: